Historical record - last NADAC publication: 1/1/2018

Product Information

MENEST 0.625 MG TABLET is a brand (anda) product labeled by Pfizer Inc., priced at $2.4046 per EA under NDC 61570007301. Its NADAC has been published 269 times since Nov 28, 2013.

MENEST 0.625 MG TABLET

esterified estrogens
$2.4046per EA
Discontinued

Strength

.625 mg/1

Manufacturer

Pfizer Inc.

NDC

61570007301

Classification

Brand (ANDA)

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2018

Active Ingredients

ESTROGENS, ESTERIFIED

Approval Type

Generic (ANDA)

FDA Application

ANDA084948

On Market Since

9/28/1977

Price Statistics

The NADAC for MENEST 0.625 MG TABLET has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 100.4%. The table below summarizes its recorded NADAC range and movement.

Current price$2.4046 per EA
All-time high$2.4046 (Jan 16, 2019)
All-time low$1.1997 (Nov 28, 2013)
Median price$1.8523
Average price$1.8395
Largest weekly change+20.0% (Jan 6, 2016)
Weeks tracked269
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+100.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the esterified estrogens market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of MENEST 0.625 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MENEST 0.625 MG TABLET, manufactured by Pfizer Inc., is $2.4046 per EA (NDC 61570007301), effective Jan 16, 2019.

How has the price of MENEST 0.625 MG TABLET changed over time?

Over the history we have for it, the NADAC for MENEST 0.625 MG TABLET has risen 100.4%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MENEST 0.625 MG TABLET?

Since Nov 28, 2013, the NADAC for MENEST 0.625 MG TABLET has ranged from a low of $1.1997 (Nov 28, 2013) to a high of $2.4046 (Jan 16, 2019), with a median of $1.8523 per EA.

Are there cheaper alternatives to MENEST 0.625 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MENEST 0.625 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures MENEST 0.625 MG TABLET?

MENEST 0.625 MG TABLET (NDC 61570007301) is labeled by Pfizer Inc., and CMS classifies it as a brand (anda) product.

Related Drugs

Same classification

No related drugs found.